德尔塔
您当前所在位置:首页 > 定制产品 > 技术中心
「同位素标记抑制剂」CAS:2749985-37-1|trans-Hydroxy Glimepiride-d4

「同位素标记抑制剂」CAS:2749985-37-1|trans-Hydroxy Glimepiride-d4

作者:德尔塔生物 日期:2025-06-09

生物活性:trans-Hydroxy Glimepiride-d4 is deuterium labeled trans-Hydroxy Glimepiride.体外研究(In Vitro):Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].德尔塔生物 has not independently confirmed the accuracy of these methods. They are for reference only.分子量:510.64Formula:C24H30D4N4O6SCAS 号:2749985-37-1非标记 CAS:600177-94-4运输条件:Room temperature in continental US; may vary elsewhere.储存方式:Please store the product under the recommended conditions in the Certificate of Analysis.纯度 & 产品资料Data Sheet (516 KB)产品使用指南 (1538 KB)参考文献[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. [Content Brief]

「同位素标记抑制剂」CAS:1126745-58-1|Ziprasidone-d8

「同位素标记抑制剂」CAS:1126745-58-1|Ziprasidone-d8

作者:德尔塔生物 日期:2025-06-09

生物活性:Ziprasidone-d88 is deuterium labeled Ziprasidone, which is a combined 5-HT (serotonin) and dopamine receptor antagonist which exhibits potent effects of antipsychotic activity.分子量:420.98Formula:C21H13D8ClN4OSCAS 号:1126745-58-1非标记 CAS:146939-27-7性状:固体颜色:Light yellow to khaki中文名称:齐拉西酮-d8运输条件:Room temperature in continental US; may vary elsewhere.储存方式:Powder:-20°C:3 years,4°C:2 yearsIn solvent:-80°C:6 months,-20°C:1 month纯度 & 产品资料Data Sheet (495 KB)产品使用指南 (1538 KB)

「同位素标记抑制剂」CAS:136765-35-0|Haloperidol-d4-1

「同位素标记抑制剂」CAS:136765-35-0|Haloperidol-d4-1

作者:德尔塔生物 日期:2025-06-09

生物活性:Haloperidol-d4-1 is deuterium labeled haloperidol, and the latter is a potent dopamine D2 receptor antagonist.IC50 & Target:D2 Receptor分子量:379.89Formula:C21H19D4ClFNO2CAS 号:136765-35-0非标记 CAS:52-86-8性状:固体颜色:White to off-white中文名称:氟哌啶醇 d4运输条件:Room temperature in continental US; may vary elsewhere.储存方式:Powder:-20°C:3 yearsIn solvent:-80°C:6 months,-20°C:1 month

「同位素标记抑制剂」CAS:2749974-94-3|W-19-d4 hydrochloride

「同位素标记抑制剂」CAS:2749974-94-3|W-19-d4 hydrochloride

作者:德尔塔生物 日期:2025-06-09

生物活性:W-19-d4 (hydrochloride) is the deuterium labeled W-19 hydrochloride[1].体外研究(In Vitro):Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].德尔塔生物 has not independently confirmed the accuracy of these methods. They are for reference only.分子量:432.40Formula:C19H19D4Cl2N3O2SCAS 号:2749974-94-3运输条件:Room temperature in continental US; may vary elsewhere.储存方式:Please store the product under the recommended conditions in the Certificate of Analysis.纯度 & 产品资料Data Sheet (522 KB)产品使用指南 (1538 KB)参考文献[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. [Content Brief]

「同位素标记抑制剂」CAS:1217719-21-5|cis-Dihydro Tetrabenazine-d7

「同位素标记抑制剂」CAS:1217719-21-5|cis-Dihydro Tetrabenazine-d7

作者:德尔塔生物 日期:2025-06-09

生物活性:cis-Dihydro Tetrabenazine-d7 is the deuterium labeled cis-Dihydro Tetrabenazine[1].体外研究(In Vitro):Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].德尔塔生物 has not independently confirmed the accuracy of these methods. They are for reference only.分子量:326.48Formula:C19H22D7NO3CAS 号:1217719-21-5运输条件:Room temperature in continental US; may vary elsewhere.储存方式:Please store the product under the recommended conditions in the Certificate of Analysis.纯度 & 产品资料Data Sheet (521 KB)产品使用指南 (1538 KB)参考文献[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-223. [Content Brief]

「同位素标记抑制剂」CAS:2642083-16-5|(Rac)-Paclobutrazol-15N3

「同位素标记抑制剂」CAS:2642083-16-5|(Rac)-Paclobutrazol-15N3

作者:德尔塔生物 日期:2025-06-09

生物活性:(Rac)-Paclobutrazol-15N3 is the 15N-labeled Rac-Paclobutrazol[1].体外研究(In Vitro):Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].德尔塔生物 has not independently confirmed the accuracy of these methods. They are for reference only.(Rac)-Paclobutrazol-15N3 相关抗体:SDHA Antibody分子量:296.77Formula:C15H20Cl15N3OCAS 号:2642083-16-5非标记 CAS:76738-62-0中文名称:(Rac)-多效唑-15N3;(Rac)-氯丁唑-15N3运输条件:Room temperature in continental US; may vary elsewhere.储存方式:Please store the product under the recommended conditions in the Certificate of Analysis.纯度 & 产品资料Data Sheet (520 KB)产品使用指南 (1538 KB)参考文献[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. [Content Brief]

「同位素标记抑制剂」CAS:1261394-10-8|Cyclobenzaprine-13C,d3 hydrochloride

「同位素标记抑制剂」CAS:1261394-10-8|Cyclobenzaprine-13C,d3 hydrochloride

作者:德尔塔生物 日期:2025-06-09

生物活性:Cyclobenzaprine-13C,d3 (hydrochloride) is the 13C- and deuterium labeled Cyclobenzaprine (hydrochloride).体外研究(In Vitro):Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[60].德尔塔生物 has not independently confirmed the accuracy of these methods. They are for reference only.Cyclobenzaprine-13C,d3 hydrochloride 相关抗体:MTNR1A Antibody分子量:315.86Formula:C1913CH19D3ClNCAS 号:1261394-10-8非标记 CAS:6202-23-9中文名称:阿米替林EP杂质B-13C,d3运输条件:Room temperature in continental US; may vary elsewhere.储存方式:Please store the product under the recommended conditions in the Certificate of Analysis.纯度 & 产品资料Data Sheet (527 KB)产品使用指南 (1538 KB)参考文献[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-223. [Content Brief][2]. Kobayashi, H., Y. Hasegawa, and H. Ono, Cyclobenzaprine, a centrally acting muscle relaxant, acts on descending serotonergic systems. Eur J Pharmacol, 1996. 311(1): p. 29-35. [Content Brief][3]. Honda, M., T. Nishida, and H. Ono, Tricyclic analogs cyclobenzaprine, amitriptyline and cyproheptadine inhibit the spinal reflex transmission through 5-HT(2) receptors. Eur J Pharmacol, 2003. 458(1-2): p. 91-9. [Content Brief]

「同位素标记抑制剂」CAS:2747918-20-1|Lercanidipine-13C,d3-1 hydrochloride

「同位素标记抑制剂」CAS:2747918-20-1|Lercanidipine-13C,d3-1 hydrochloride

作者:德尔塔生物 日期:2025-06-09

生物活性:Lercanidipine-13C,d3-1 (hydrochloride) is deuterium labeled Lercanidipine (hydrochloride). Lercanidipine hydrochloride is a lipophilic third-generation dihydropyridine-calcium channel blocker (DHP-CCB). Lercanidipine hydrochloride has long lasting antihypertensive action and reno-protective effect[1][2][3].体外研究(In Vitro):Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].德尔塔生物 has not independently confirmed the accuracy of these methods. They are for reference only.Lercanidipine-13C,d3-1 hydrochloride 相关抗体:Annexin VI AntibodyCalbindin AntibodyCalreticulin AntibodyCardiac Troponin I/TNNC1 AntibodySCGN Antibody (YA1167)RAMP1 Antibody (YA1818)Annexin V Antibody (YA1829)Striatin 4 Antibody (YA2088)Fibulin 5 Antibody (YA2448)RASGRP1 Antibody (YA2546)Fibulin 1 Antibody (YA2831)EFEMP1 Antibody (YA2883)CRCP Antibody (YA3350)Annexin VII Antibody (YA1138)Parvalbumin Antibody (YA1249)Annexin IV Antibody (YA1921)SERCA2 ATPase Antibody (YA1931)Stromal Interaction Molecule 1 Antibody (YA2092)SERCA1 ATPase Antibody (YA2157)TrpV5 Antibody (YA2284)NCX1 Antibody (YA2331)Scramblase 1 Antibody (YA2419)CAB39 Antibody (YA2761)CUG BP1 Antibody (YA2806)C10orf63 Antibody (YA2894)ITPK1 Antibody (YA3125)ORAI3 Antibody (YA3128)ORAI1 Antibody (YA3157)CREB Regulated Transcription Coactivator 2 Antibody (YA3279)分子量:652.20Formula

「同位素标记抑制剂」CAS:2517756-06-6|Lamotrigine-13C,d3

「同位素标记抑制剂」CAS:2517756-06-6|Lamotrigine-13C,d3

作者:德尔塔生物 日期:2025-06-09

生物活性:Lamotrigine-13C,d3 is the 13C- and deuterium labeled Lamotrigine. Lamotrigine (BW430C) is a potent and orally active anticonvulsant or antiepileptic agent. Lamotrigine selectively blocks voltage-gated Na+ channels, stabilizing presynaptic neuronal membranes and inhibiting glutamate release. Lamotrigine can be used for the research of epilepsy, focal seizure, et al[1][2].体外研究(In Vitro):Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[84].德尔塔生物 has not independently confirmed the accuracy of these methods. They are for reference only.Lamotrigine-13C,d3 相关抗体:xCT Antibody (YA006)xCT Antibody (YA652)Alpha-ENaC AntibodyCRMP2 Antibody (YA3370)SLC12A1 Antibody (YA1403)CRMP1 Antibody (YA1941)CRMP5 Antibody (YA2497)CRMP3 Antibody (YA2563)CRMP4 Antibody (YA2777)分子量:260.10Formula:C813CH4D3Cl2N5CAS 号:2517756-06-6非标记 CAS:84057-84-1中文名称:拉莫三嗪-13C,d3;那蒙特金-13C,d3运输条件:Room temperature in continental US; may vary elsewhere.储存方式:Please store the product under the recommended conditions in the Certificate of Analysis.纯度 & 产品资料Data Sheet (536 KB)产品使用指南 (1538 KB)参考文献[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-223. [Content Brief][2]. M J Leach, et al. Pharmacological studies on lamotrigine,

「同位素标记抑制剂」CAS:2744683-81-4|Famotidine-13C,d3

「同位素标记抑制剂」CAS:2744683-81-4|Famotidine-13C,d3

作者:德尔塔生物 日期:2025-06-09

生物活性:Famotidine-13C,d3 is the 13C- and deuterium labeled Famotidine. Famotidine (MK-208) is a competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.IC50 & Target:H2 Receptor体外研究(In Vitro):Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[63].德尔塔生物 has not independently confirmed the accuracy of these methods. They are for reference only.Famotidine-13C,d3 相关抗体:ADGRE1 (F4/80) Antibody (YA002)ADGRE1 (F4/80) Antibody (YA920)分子量:341.46Formula:C713CH12D3N7O2S3CAS 号:2744683-81-4非标记 CAS:76824-35-6中文名称:法莫替丁-13C,d3;法莫丁-13C,d3运输条件:Room temperature in continental US; may vary elsewhere.储存方式:Please store the product under the recommended conditions in the Certificate of Analysis.纯度 & 产品资料Data Sheet (524 KB)产品使用指南 (1538 KB)参考文献[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-223. [Content Brief][2]. Inan, A., et al., Effects of the histamine H2 receptor antagonist famotidine on the healing of colonic anastomosis in rats. Clinics (Sao Paulo), 2009. 64(6): p. 567-70. [Content Brief][3]. Miyata, K., et al., Studies on the mechanism for the gastric mucosal protection by famotidine in rats. Jpn J Pharmacol, 1991. 55(2): p. 211-22. [Con

「同位素标记抑制剂」CAS:2747917-88-8|Methocarbamol-13C,d3

「同位素标记抑制剂」CAS:2747917-88-8|Methocarbamol-13C,d3

作者:德尔塔生物 日期:2025-06-09

生物活性:Methocarbamol-13C,d3 is the 13C- and deuterium labeled Methocarbamol. Methocarbamol is an orally active central muscle relaxant and blocks muscular Nav1.4 channel. Methocarbamol reversibly affects voltage dependence of inactivation of Nav1.4 channel. Methocarbamol has the potential for muscle spasms and pain syndromes research[1][2][3].体外研究(In Vitro):Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[79].德尔塔生物 has not independently confirmed the accuracy of these methods. They are for reference only.Methocarbamol-13C,d3 相关抗体:xCT Antibody (YA006)xCT Antibody (YA652)Alpha-ENaC AntibodyCRMP2 Antibody (YA3370)SLC12A1 Antibody (YA1403)CRMP1 Antibody (YA1941)CRMP5 Antibody (YA2497)CRMP3 Antibody (YA2563)CRMP4 Antibody (YA2777)分子量:245.25Formula:C1013CH12D3NO5CAS 号:2747917-88-8非标记 CAS:532-03-6中文名称:美索巴莫-13C,d3;舒筋灵-13C,d3;甲氧氨酯-13C,d3运输条件:Room temperature in continental US; may vary elsewhere.储存方式:Please store the product under the recommended conditions in the Certificate of Analysis.纯度 & 产品资料Data Sheet (530 KB)产品使用指南 (1538 KB)参考文献[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-223. [Content Brief][2]. Bruce, R.B., L.B. Turnbull, and J.H. Newman, Metabolism of methocarbamol in th

「同位素标记抑制剂」CAS:2699607-85-5|Ondansetron-13C,d3

「同位素标记抑制剂」CAS:2699607-85-5|Ondansetron-13C,d3

作者:德尔塔生物 日期:2025-06-09

生物活性:Ondansetron-13C,d3 is the 13C- and deuterium labeled Ondansetron[1].体外研究(In Vitro):Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[27].德尔塔生物 has not independently confirmed the accuracy of these methods. They are for reference only.Ondansetron-13C,d3 相关抗体:MTNR1A Antibody分子量:297.37Formula:C1713CH16D3N3OCAS 号:2699607-85-5非标记 CAS:99614-02-5中文名称:昂丹司琼-13C,d3;恩丹西酮-13C,d3;昂旦司琼-13C,d3;奥旦西隆-13C,d3;翁丹色创-13C,d3;翁丹西隆-13C,d3;翁旦斯隆-13C,d3;蒽丹西酮-13C,d3运输条件:Room temperature in continental US; may vary elsewhere.储存方式:Please store the product under the recommended conditions in the Certificate of Analysis.纯度 & 产品资料Data Sheet (529 KB)产品使用指南 (1538 KB)参考文献[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-223. [Content Brief][2]. Brown AM, et al. Ion permeation and conduction in a human recombinant 5-HT3 receptor subunit (h5-HT3A). J Physiol. 1998 Mar 15;507 ( Pt 3):653-65. [Content Brief][3]. Barann M, et al. Recombinant human 5-HT3A receptors in outside-out patches of HEK 293 cells: basic properties and barbiturate effects. Naunyn Schmiedebergs Arch Pharmacol. 2000 Sep;362(3):255-65. [Content Brief][4]. Wildeboer KM, et al. Ondansetron results in improved auditory

「同位素标记抑制剂」CAS:81586-94-9|Alpha-Estradiol-d2

「同位素标记抑制剂」CAS:81586-94-9|Alpha-Estradiol-d2

作者:德尔塔生物 日期:2025-06-09

生物活性:Alpha-Estradiol-d2 is the deuterium labeled Alpha-Estradiol. Alpha-Estradiol is a weak estrogen and a 5α-reductase inhibitor which is used as a topical medication in the treatment of androgenic alopecia[1].体外研究(In Vitro):Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].德尔塔生物 has not independently confirmed the accuracy of these methods. They are for reference only.Alpha-Estradiol-d2 相关抗体:BNSP AntibodyFACL4 AntibodyBrdU Antibody (YA578)GAPDH AntibodyGlucose 6 Phosphate Dehydrogenase AntibodyMETTL3 AntibodyTSG101 AntibodyAlkaline Phosphatase AntibodyCalnexin Antibody (YA573)Lamin A/C AntibodyLamin B1 AntibodyLAMP1 AntibodyLAMP2 Antibody (YA713)LAMP2a AntibodyNQO1 Antibody (YA697)NQO1 Antibody (YA261)OPA1 AntibodyRBM3 AntibodySynaptophysin Antibody (YA043)Laminin beta 1 AntibodyHeme Oxygenase 1 AntibodyKi67 Antibody (YA717)Ki67 Antibody (YA322)Asparagine Synthetase AntibodyCalnexin AntibodyKi67 Antibody (YA001)Osteopontin AntibodySynaptophysin Antibody (YA664)TREM2 AntibodyGAPDH Antibody (YA848)分子量:274.39Formula:C18H22D2O2CAS 号:81586-94-9非标记 CAS:57-91-0性状:固体颜色:White to off-white中文名称:雌二醇EP杂质L (17-epi-Estradiol)-d2运输条件:Room temperature in continental US; may vary elsewhere.储存方式:Powder:-20°C:3 years,4°C:2 yearsIn solvent:-80°C:6 months,-20°C:1 month

「同位素标记抑制剂」CAS:2712126-48-0|Imiquimod-d9

「同位素标记抑制剂」CAS:2712126-48-0|Imiquimod-d9

作者:德尔塔生物 日期:2025-06-09

生物活性:Imiquimod-d9 is deuterium labeled Imiquimod. Imiquimod (R 837), an immune response modifier, is a selective toll like receptor 7 (TLR7) agonist. Imiquimod exhibits antiviral and antitumor effects in vivo. Imiquimod can be used for the research of external genital, perianal warts, cancer and COVID-19[1][2].体外研究(In Vitro):Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].德尔塔生物 has not independently confirmed the accuracy of these methods. They are for reference only.Imiquimod-d9 相关抗体:IRF3 AntibodyToll-Like Receptor 4 AntibodyToll-Like Receptor 3 AntibodyTLR2 AntibodyToll-Like Receptor 2 Antibody (YA1932)TRIF Antibody (YA2263)TIRAP Antibody (YA2589)Toll-Like Receptor 9 Antibody (YA3321)Toll-Like Receptor 7 Antibody (YA2514)Toll-Like Receptor 5 Antibody (YA3265)分子量:249.36Formula:C14H7D9N4CAS 号:2712126-48-0非标记 CAS:99011-02-6中文名称:咪喹莫特-d9运输条件:Room temperature in continental US; may vary elsewhere.储存方式:Please store the product under the recommended conditions in the Certificate of Analysis.纯度 & 产品资料Data Sheet (538 KB)产品使用指南 (1538 KB)参考文献[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. [Content Brief][2]. Athina Angelopoulou, et al. Imiquimod - A toll like receptor 7 agonist - Is

「同位素标记抑制剂」CAS:2342573-59-3|Prostaglandin E1-d9

「同位素标记抑制剂」CAS:2342573-59-3|Prostaglandin E1-d9

作者:德尔塔生物 日期:2025-06-09

生物活性:Prostaglandin E1-d9 is deuterium labeled Prostaglandin E1.Prostaglandin E1 is a prostanoid receptor ligand, with Kis of 1.1 nM, 2.1 nM, 10 nM, 33 nM and 36 nM for mouse EP3, EP4, EP2, IP and EP1, respectively. Prostaglandin E1 induces vasodilation and inhIC50 & Target:EP体外研究(In Vitro):Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[4].德尔塔生物 has not independently confirmed the accuracy of these methods. They are for reference only.Prostaglandin E1-d9 相关抗体:BNSP AntibodyFACL4 AntibodyBrdU Antibody (YA578)GAPDH AntibodyGlucose 6 Phosphate Dehydrogenase AntibodyMETTL3 AntibodyTSG101 AntibodyAlkaline Phosphatase AntibodyCalnexin Antibody (YA573)Lamin A/C AntibodyLamin B1 AntibodyLAMP1 AntibodyLAMP2 Antibody (YA713)LAMP2a AntibodyNQO1 Antibody (YA697)NQO1 Antibody (YA261)OPA1 AntibodyRBM3 AntibodySynaptophysin Antibody (YA043)Laminin beta 1 AntibodyHeme Oxygenase 1 AntibodyKi67 Antibody (YA717)Ki67 Antibody (YA322)Asparagine Synthetase AntibodyCalnexin AntibodyKi67 Antibody (YA001)Osteopontin AntibodySynaptophysin Antibody (YA664)TREM2 AntibodyGAPDH Antibody (YA848)分子量:363.54Formula:C20H25D9O5CAS 号:2342573-59-3非标记 CAS:745-65-3中文名称:前列地尔-d9;前列腺素E1-d9;列腺素E1-d9运输条件:Room temperature in continental US; may vary elsewhere.储存方式:Please store the product under the recommended condi